×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Principal Investigator  
Principal Investigator's Name: Jia Fan
Institution: The second hospital of Jilin University
Department: Neurology
Country:
Proposed Analysis: We proposed to analyse the data of ADNI like demographic characteristics, clinical data,some subscales of neuropsychologicalscreens, dneuroimaging results ,biomarkers data and our Chinese data. Try to understand the similarities and differences between Chinese and white patients with AD and MCI. That is important because any ethnic-specifific differences could impact the interpretation of research or clinical trials utilizing diverse participants, particularly if clinical or neuroimaging measures are used to assess treatment outcome.
Additional Investigators  
Investigator's Name: Shanji Nan
Proposed Analysis: We proposed to analyse the data of ADNI like demographic characteristics, clinical data and some subscales of neuropsychological screens,and neuroimaging results ,biomarkers data and our Chinese data. Try to understand the similarities and differences between Chinese and white patients with AD and MCI. That is important because any ethnic-specifific differences could impact the interpretation of research or clinical trials utilizing diverse participants, particularly if clinical or neuroimaging measures are used to assess treatment outcome.
Investigator's Name: Yuke Ma
Proposed Analysis: We proposed to analyse the data of ADNI like demographic characteristics, clinical data and some subscales of neuropsychological screens,and neuroimaging results ,biomarkers data and our Chinese data. Try to understand the similarities and differences between Chinese and white patients with AD and MCI. That is important because any ethnic-specifific differences could impact the interpretation of research or clinical trials utilizing diverse participants, particularly if clinical or neuroimaging measures are used to assess treatment outcome.